stockrowAbbott Laboratories (ABT) vs Edwards Lifesciences Corporation (EW)
- Abbott Laboratories ABT 110.37 −2.84%
- Edwards Lifesciences Corporation EW 101.39 +0.57%
Abbott Laboratories and Edwards Lifesciences Corporation are both Medical Devices companies. Abbott Laboratories is the larger, with a market value of $196.6B against $58.1B — 3.4× the size. Abbott Laboratories trades at the lower P/E: 42.3× against 56.7×. Edwards Lifesciences Corporation grew revenue faster over the last twelve months: 13.4% against 10.0%. Edwards Lifesciences Corporation has the higher net margin (15.3% vs 9.75%) and the higher return on invested capital (7.79% vs 0.00%). Across the 22 metrics below, Edwards Lifesciences Corporation leads on 12 and Abbott Laboratories on 10.
Valuation
Profitability
| Metric | ABT | EW | Medical Devices median |
|---|---|---|---|
| Gross margin | 56.94% | 78.02% | 57.76% |
| Operating margin | 13.78% | 21.59% | (15.07%) |
| Net margin | 9.75% | 15.30% | (14.45%) |
| Free cash flow margin | 0.00% | 21.34% | (3.88%) |
| Return on equity | 0.00% | 9.65% | (10.35%) |
| Return on assets | 0.00% | 7.45% | (17.26%) |
| Return on invested capital | 0.00% | 7.79% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack